[PDF] snmjournals.orgFree from Publisher

124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer: results of a multicenter diagnostic …

JW Kist, B de Keizer, M van der Vlies… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Patients with suspected recurrence from differentiated thyroid carcinoma, based on an
increased thyroglobulin (Tg) level and negative neck ultrasound (US), pose a clinical …
Save Cite Cited by 42 Related articles All 8 versions
[HTML] springer.comFull View

[HTML][HTML] Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study …

JW Kist, B de Keizer, MPM Stokkel, OS Hoekstra… - BMC cancer, 2014 - Springer
Background After initial treatment of differentiated thyroid carcinoma (DTC) patients are
followed with thyroglobulin (Tg) measurements to detect recurrences. In case of elevated …
Save Cite Cited by 26 Related articles All 20 versions
[HTML] nih.gov

Do Negative 124I Pretherapy Positron Emission Tomography Scans in Patients with Elevated Serum Thyroglobulin Levels Predict Negative 131I Posttherapy Scans?

GR Khorjekar, D Van Nostrand, C Garcia, J O'Neil… - Thyroid, 2014 - liebertpub.com
Background: The management of patients with differentiated thyroid cancer (DTC) who have
elevated serum thyroglobulin (Tg) levels and negative 131I or 123I scans is problematic …
Save Cite Cited by 34 Related articles All 8 versions
[HTML] springer.com

[HTML][HTML] 131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?

G Treglia, F Bertagna, A Piccardo… - Clinical and Translational …, 2013 - Springer
The aim of this review is to discuss the current role of iodine-131 (131 I) whole-body
scanning (WBS) and fluorine-18-fluorodeoxyglucose positron emission tomography (18 …
Save Cite Cited by 24 Related articles All 5 versions
[PDF] researchgate.net

[PDF][PDF] Could [18] F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?

A Piccardo, L Foppiani, S Morbelli… - Quarterly Journal of …, 2011 - researchgate.net
Aim. Stage-IV differentiated thyroid cancer (DTC) patients may present elevated serum
thyroglobulin (Tg) levels associated with positive [131I] whole-body-scan (WBS) …
Save Cite Cited by 23 Related articles All 6 versions
[PDF] snmjournals.orgFree from Publisher

Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate–to–high-risk patients with differentiated thyroid cancer: dual-center experience with …

JW Lee, SM Lee, DH Lee, YJ Kim - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
Patients with differentiated thyroid carcinoma (DTC) are treated with 131I therapy after total
thyroidectomy or surgical resection of recurrent tumor. However, some recurrent DTC …
Save Cite Cited by 67 Related articles All 8 versions

Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning

C Pettinato, E Spezi, C Nanni, G Grassetto… - Clinical nuclear …, 2014 - journals.lww.com
Purpose This study evaluates the use of sequential 124 I PET/CT for predicting absorbed
doses to metastatic lesions in patients with differentiated thyroid cancer undergoing 131 I …
Save Cite Cited by 29 Related articles All 6 versions
[PDF] wiley.com

Utility of I‐124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta‐analysis

P Santhanam, D Taieb, L Solnes… - Clinical …, 2017 - Wiley Online Library
Introduction Diagnostic I‐123 scans have been shown to underestimate the disease burden
in differentiated thyroid cancer (DTC) when compared to I‐131 post‐treatment scans …
Save Cite Cited by 49 Related articles All 6 versions

Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body …

P Bannas, T Derlin, M Groth, I Apostolova… - Annals of nuclear …, 2012 - Springer
Background Exact localization of recurrent iodine-negative thyroid cancer is mandatory,
since surgery is the only curative therapy option in patients with iodine-negative tumor …
Save Cite Cited by 63 Related articles All 10 versions
[PDF] rug.nl

18-fluorodeoxyglucose positron emission tomography in the early diagnostic workup of differentiated thyroid cancer patients with a negative post-therapeutic iodine …

D van Dijk, JTM Plukker, HTT Phan, AC Muller Kobold… - Thyroid, 2013 - liebertpub.com
Background: Surgery and high-dose radioactive iodine (131I) treatment are the
cornerstones in the treatment of differentiated thyroid cancer. Patients without 131I uptake …
Save Cite Cited by 17 Related articles All 8 versions